{
  "trial_id": "NCT02645786",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "age",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "thyroid cancer group",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "no history of structural heart disease, arrhythmia, or cardiac symptoms",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "who had arrhythmia in electrography or history of cardiac disease",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of CAD, atrial fibrillation, and hypertension, which may affect thyroxine metabolism and cardiac structure.",
  "_meta": {
    "topic_id": "15",
    "trial_id": "NCT02645786",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}